Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest Clinical Trials & Medical Discoveries

01 Jun, 2018, 08:00 BST Enterome to Feature Promising Phase 1 Clinical Data With its Lead Candidate EB8018 for Crohn's Disease at the Digestive Disease Week 2018

Enterome SA, a clinical-stage biotech company pioneering innovative therapies to treat microbiome-associated diseases with a focus on inflammatory...


31 May, 2018, 16:56 BST NW Bio To Discuss Interim Phase 3 Trial Data In Industry Theater Session During ASCO

Northwest Biotherapeutics (OTCQB: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers,...


31 May, 2018, 13:00 BST Daiichi Sankyo Initiates Phase 2 Study of DS-8201 in Patients with Advanced HER2-Overexpressing or HER2-Mutated Non-Squamous Non-Small Cell Lung Cancer

- Global phase 2 study will evaluate safety and efficacy of DS-8201 in patients with unresectable and/or metastatic non-squamous...


31 May, 2018, 11:42 BST Nordic Nanovector to Present Pre-clinical Study of Betalutin® Effect on NHL Cells at European Hematology Association Meeting

Nordic Nanovector ASA (OSE: NANO) announces that it will present a poster describing a preclinical analysis of genetic factors that correlate with...


31 May, 2018, 11:00 BST Clinical Evaluation of Sysmex Inostics' Plasma NGS Liquid Biopsy Technology to Complement Mammography When Screening for Early Stage Breast Cancer Presented at the 2018 ASCO Annual Meeting

Sysmex Inostics, a global leader in blood based circulating tumor DNA (ctDNA) analysis, today announced that preliminary clinical results of a...


30 May, 2018, 08:00 BST LimaCorporate Celebrating 20 Years of Hip Revision Surgery

LimaCorporate is proud to announce that the Revision Stem has achieved 20 years of clinical heritage in the Orthopaedic market. This anniversary...


30 May, 2018, 02:00 BST ASSOCHAM Pharma Excellence Awards 2018 Privileged Veeda Clinical Research With 'Best Clinical Research 2018' Award

On 9th May 2018, Veeda Clinical Research an Independent Indian CRO has been honored with Best Clinical Research 2018 by the Associated Chambers...


29 May, 2018, 22:43 BST NWBio Announces Scientific Publication of Interim Survival Data From Phase 3 Trial of DCVax®-L for Glioblastoma Brain Cancer

Median survival of top 100 patients is 40.5 months, Median survival of all 331 patients is 23.1 months, Longest survivors have exceeded 7 years...


29 May, 2018, 11:11 BST UK's National Institute for Health and Care Excellence Reviews Medial EarlySign's Predictive AI Model for Identifying People at Risk of Colorectal Cancer

Recognition by NICE Serves as Global Benchmark for High Quality Healthcare Solutions Medial EarlySign (http://www.earlysign.com), a leader in...


29 May, 2018, 09:12 BST OliX Pharmaceuticals receives Clinical Trial Authorization in the UK to initiate Phase I study with OLX10010, an anti-scar RNAi therapeutics

OliX Pharmaceuticals Inc., a leading developer of RNA interference (RNAi) therapeutics (CEO: Dong-ki Lee, Ph.D.), announced that it received the...


29 May, 2018, 07:26 BST BerGenBio - Invitation to Conference Call: Interim Update on Ph II Clinical Programme With Selective AXL Inhibitor Bemcentinib Being Presented at ASCO

BerGenBio ASA (OSE:BGBIO) will host a conference call on Monday, 4 June at 8:30 AM CEST to present updated interim clinical and biomarker results...


25 May, 2018, 19:43 BST Getinge announces results from SEMPER FI pilot study of intra-aortic balloon pump showing numerical trend toward reduced mortality in patients with extensive myocardial infarction and persistent ischemia

Study results presented at EuroPCR 2018 Getinge, a leading global provider of innovative medical technology, today announced results from the...


25 May, 2018, 18:18 BST Nordic Nanovector Updates on Clinical Trial Applications for Archer-1 and PARADIGME Trials in Norway

Nordic Nanovector ASA (OSE: NANO) has received feedback from the Regional Committees for Medical and Health Research Ethics (REK) in Norway with...


25 May, 2018, 07:00 BST Significant Achievement for OstomyCure AS and TIES®Solution

Approval for multicenter study "TIES-C03" in major university hospitals in Leeds, UK & Umeå, Sweden. OstomyCure AS has achieved an important...


24 May, 2018, 12:14 BST Targovax Strengthens 2-year Survival Rate in Resected Pancreatic Cancer With TG01

Targovax ASA ("Targovax" or "the Company") (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid...


24 May, 2018, 12:00 BST PiCSO therapy reduces infarct size in STEMI patients.

Miracor Medical announces new publication at EuroPCR. Miracor Medical SA announced today the clinical results from the physician-sponsored...


24 May, 2018, 12:00 BST Oxitec Launches Field Trial in Brazil for Next Generation Addition to Friendly™ Mosquitoes Platform

Significant technology advancements set stage for targeted, multi-generation suppression of disease-transmitting mosquitoes Oxitec Ltd,...


24 May, 2018, 09:07 BST Hay Fever Patients can Benefit From Probiotics, According to a Research by Griffith University and Winclove Probiotics

New research from Griffith University, Australia, published today in the Journal of Alternative and Complementary Medicine, shows a...


24 May, 2018, 07:00 BST eTheRNA Completes Enrolment of Low Dose Cohort for Phase 1b Study of TriMix mRNA-Based Cancer Specific Immunotherapy (ECI-006) in Melanoma

ECI-006 is safe and well tolerated eTheRNA immunotherapies, a clinical-stage company developing novel cancer immunotherapies based on its...


24 May, 2018, 07:00 BST Real-World Evidence Shows Clinically Meaningful Weight Loss in People Receiving Saxenda®

People treated with Saxenda® (liraglutide 3 mg) for weight management lost an average of 8.1 kg after six months in a real-world clinical setting,...


24 May, 2018, 00:20 BST CeloNova Announces Positive Clinical Results of eCOBRA Study at EuroPCR 2018

1-year outcomes demonstrate COBRA PzF NanoCoated Coronary Stent (NCS) is a safe and effective treatment for patients at high risk of bleeding and...


23 May, 2018, 19:18 BST Positive Two-Year Data from MiStent® DESSOLVE III Trial Presented at EuroPCR

- Excellent safety and low target lesion revascularization (TLR) rates persist - A 24-month update on the DESSOLVE III trial of the MiStent®...


23 May, 2018, 19:00 BST A Capsule Against Cancer: NUST MISIS Scientists' Development Doubles Lifetime of Sick Animals

A research team from NUST MISIS and Pirogov Russian National Research Medical University (RNRMU) has successfully conducted preclinical trials...


23 May, 2018, 17:01 BST Pivotal Clinical Trial Demonstrates Superiority of Anular Closure Compared to Standard Lumbar Discectomy

Intrinsic Therapeutics, Inc., a medical device company focusing on spinal disc therapies, today announced the publication of two-year results from...


23 May, 2018, 15:03 BST MicroPort(TM)'s Firehawk(TM) Drug Eluting Stent Achieves Primary Endpoint and Shows Very Promising Results From TARGET All-Comers Clinical Trial

Today MicroPort Scientific Corporation (HKSE: 0853) ("MicroPort™") announced primary endpoint data at 12 months and QCA angiography data at 13...


Most Viewed Clinical Trials & Medical Discoveries